Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18386055 | 0.92 | PDK2 (0.39) | MEN1KMT2ASMN1; SMN2MAPTKDM4E | |
| SCHEMBL18386054 | 0.92 | ESR1 (0.35) | MEN1KMT2ASMN1; SMN2MAPTKDM4E | |
| SCHEMBL18708074 | 0.85 | PDK2 (0.33) | MEN1KMT2ASMN1; SMN2MAPTKDM4E | |
| SCHEMBL26807388 | 0.84 | PDK2 (0.35) | MEN1KMT2ASMN1; SMN2MAPTKDM4E | |
| SCHEMBL26457903 | 0.84 | MAPK1 (0.31) | SMN1; SMN2ESR1ESR2L3MBTL1NPC1 | |
| SCHEMBL18386051 | 0.83 | PDK2 (0.40) | SMN1; SMN2ESR1ESR2PDK2L3MBTL1 | |
| SCHEMBL18708070 | 0.83 | MEN1 (0.42) | MEN1KMT2ASMN1; SMN2MAPTKDM4E | |
| SCHEMBL18386049 | 0.77 | KDM4E (0.34) | MEN1KMT2ASMN1; SMN2MAPTKDM4E | |
| SCHEMBL18708069 | 0.77 | PDK2 (0.39) | SMN1; SMN2PDK2L3MBTL1NPC1MAPK1 | |
| SCHEMBL18386048 | 0.76 | PDK2 (0.35) | MEN1KMT2ASMN1; SMN2MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877510-B2 | Heterocyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2024-01-16 | — | — | US | disclosed |
| US-20170098777-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-04-06 | — | — | US | disclosed |
| US-20170033294-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-02-02 | — | — | US | disclosed |
| US-20170018718-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170033294-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | MEN1 822/4885KMT2A 518/4885SMN1; SMN2 3822/4885 |
| US-20170018718-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | MEN1 822/4885KMT2A 518/4885SMN1; SMN2 3822/4885 |
| US-20170098777-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CRY2, PER2 | MEN1 908/4885KMT2A 696/4885SMN1; SMN2 4064/4885 |
| US-11877510-B2 | Heterocyclic compound and organic light-emitting element comprising same | CRY1, CRY2, PER2 | MEN1 822/4885KMT2A 518/4885SMN1; SMN2 3822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.